Sign In
Buy DNA
$7.89
-0.110 (-1.38%)
At Close: Jun 12, 2026
3 Unstoppable Growth Stocks to Buy in 2022 and Beyond
11:45am, Thursday, 10'th Mar 2022
There is no shortage of opportunities for these businesses to get much bigger in the years ahead.
2 Growth Stocks That Wall Street Thinks Can Double in Value
11:15am, Thursday, 24'th Feb 2022
From biotech to blockchain, there is no shortage of growth opportunities here.
Is This SPAC a Buy After Falling More Than 50%?
11:15am, Friday, 18'th Feb 2022
Ginkgo Bioworks is still a story stock and one that's expensive to buy into.
7 Stocks to Buy After Sentiment Slipped to Lows
12:30pm, Thursday, 17'th Feb 2022
With sentiment souring over inflation and other concerns, contrarians may have an opportunity to bank on certain stocks to buy like these. The post 7 Stocks to Buy After Sentiment Slipped to Lows appe
Ginkgo Bioworks Announces Participation in Upcoming Conferences
04:00pm, Tuesday, 08'th Feb 2022
BOSTON, Feb. 8, 2022 /PRNewswire/ -- Ginkgo Bioworks (NYSE: DNA), the leading horizontal platform for cell programming, announced today that management is scheduled to participate in the following up
Best Penny Stocks to Buy Next Month? Check These 3 Out
05:00pm, Friday, 28'th Jan 2022
Can these penny stocks push up next month? The post Best Penny Stocks to Buy Next Month?
Why BofA Sees 'Better Entry Point' In Ginkgo Bioworks Stock
11:20am, Friday, 28'th Jan 2022
Ginkgo Bioworks Holdings Inc DNA is “at the forefront of the rising SynBio wave, a market we think holds much long-term promise,” according to BofA Securities. The Ginkgo Bioworks Analyst: Derik d
Andreas Halvorsen Gets in on Amylyx Pharmaceuticals' IPO
12:59pm, Tuesday, 25'th Jan 2022
Andreas Halvorsen (Trades, Portfolio), chief investment officer of Viking Global Investors, disclosed a stake in Amylyx Pharmaceuticals Inc. ( AMLX , Financial) late last week.
Ginkgo Bioworks Announces Acquisition Of Massachusetts COVID-19 Testing Provider Project Beacon COVID-19 LLC; Terms Not Disclosed
07:04am, Wednesday, 19'th Jan 2022
Acquisition to enable Ginkgo to bolster its growing biosecurity platform and provide expanded COVID-19 testing options to communities in Massachusetts and beyond BOSTON, Jan. 19, 2022 /PRNewswire/ --
Why Ginkgo Bioworks Shares Are Trading Higher Today
09:22am, Wednesday, 12'th Jan 2022
Ginkgo Bioworks Holdings Inc (NYSE: DNA) is trading higher Wednesday after the company reported preliminary unaudited 2021 revenue highlights and a business review. Ginkgo Bioworks said it expects to
Ginkgo Bioworks Holdings, Inc. (DNA) Could Find Support Soon, Here's Why You Should Buy the Stock Now
12:19pm, Tuesday, 11'th Jan 2022
Ginkgo Bioworks Holdings, Inc. (DNA) witnesses a hammer chart pattern, indicating support found by the stock after losing some value lately. This coupled with an upward trend in earnings estimate revi
Cathie Wood's ARK Invest Buys Over 2.1 Million Shares of Ginkgo Bioworks
07:45am, Friday, 07'th Jan 2022
A couple of ARK Invest exchange-traded funds run by ETF star Cathie Wood made a huge buy on Thursday.
Ginkgo Bioworks: World's First Synthetic Biology Syndicate
05:27pm, Monday, 03'rd Jan 2022
Ginkgo has had a lackluster stock performance since IPO. I believe there is intrinsic value in their technology and financing.
Cathie Wood's ARK Invest Buys Nearly 1.5 Million Shares of Ginkgo Bioworks
08:05am, Thursday, 02'nd Dec 2021
A couple of ARK Invest exchange-traded funds run by ETF star Cathie Wood made a huge buy on Wednesday.
Andreas Halvorsen Dives Into Ginkgo Bioworks, Adds to Humana
03:23pm, Wednesday, 01'st Dec 2021
Viking Global leader Andreas Halvorsen (Trades, Portfolio) disclosed his portfolio for the third quarter in November.
